ARION R&D Center has successfully passed the audits regarding the activities of 2021!

In the evaluation made by the Evaluation and Inspection Commission, it was unanimously approved by the members attending the Evaluation and Inspection Commission meeting that the ARION R&D Center continues to benefit from the incentives and exemptions provided to the R&D Centers under the Law No. 5746. With the aim of developing products for the Veterinary Pharmaceutical sector to protect the environment, human and animal health, our domestic and foreign partnership projects continue in 2022 with our valuable professors from respected universities of our country.

Arion Medicine

Latest articles